|
|
Volumn 88, Issue 7, 2009, Pages 699-700
|
|
Clinical efficacy of vorinostat in a patient with essential thrombocytosis and subsequent myelofibrosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
ANAGRELIDE;
BCR ABL PROTEIN;
HEMOGLOBIN;
HYDROXYUREA;
JANUS KINASE 2;
RECOMBINANT ERYTHROPOIETIN;
THALIDOMIDE;
TRICHOSTATIN A;
VORINOSTAT;
AGED;
ANEMIA;
BLOOD CELL COUNT;
BONE MARROW BIOPSY;
CASE REPORT;
CEREBROVASCULAR ACCIDENT;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ERYTHROCYTE TRANSFUSION;
FEMALE;
GENE MUTATION;
HUMAN;
LETTER;
LITHOTRIPSY;
MALE;
MYELOFIBROSIS;
NEPHROLITHIASIS;
PRIORITY JOURNAL;
RECURRENT DISEASE;
THROMBOCYTE COUNT;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOSIS;
TREATMENT OUTCOME;
URETER STENT;
AGED;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTINEOPLASTIC AGENTS;
BLOOD TRANSFUSION;
HUMANS;
HYDROXAMIC ACIDS;
MALE;
PLATELET COUNT;
PRIMARY MYELOFIBROSIS;
THROMBOCYTHEMIA, ESSENTIAL;
TREATMENT OUTCOME;
|
|
EID: 67349127967
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s00277-008-0640-3 Document Type: Letter |
|
Times cited : (10)
|
|
References (5)
|
